medroxyprogesterone acetate has been researched along with Bone Loss, Osteoclastic in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 12 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aisaka, K | 1 |
| Ohta, H; Onoe, Y | 1 |
| Sucato, GS | 1 |
| Bonny, A; Cromer, BA; Lazebnik, R; Rome, E; Secic, M; Stager, M; Ziegler, J | 1 |
| Falbo, A; Lombardi, G; Manguso, F; Mastrantonio, P; Nunziata, V; Orio, F; Palomba, S; Russo, T; Tolino, A; Zullo, F | 1 |
| Sarne, DH | 1 |
| Berenson, A; Clark, MK; Cromer, BA; Cundy, T; Kaunitz, AM; Scholes, D | 1 |
| Constant, D; Cooper, D; Hoffman, M; Kalla, AA; Micklesfield, L; Rosenberg, L; Zhang, Y | 1 |
| Arias, R; Kaunitz, AM; McClung, M | 1 |
| Cosman, F; Lindsay, R; Nieves, J; Shen, V | 1 |
| Christiansen, C; Dequinze, B; Deroisy, R; Franchimont, P; Gaspard, U; Reginster, JY; Taquet, AN | 1 |
| Atley, L; Ebeling, PR; Eyre, DR; Lentle, BC; Li, DK; Prior, JC; Vigna, YM; Wark, JD | 1 |
| Fan, S; Li, B; Tang, G; Tang, OS; Yip, P | 1 |
| Harada, A; Hosoi, T; Ikeda, K; Miyauchi, A; Ohta, H; Shiraki, M; Yamada, Y | 1 |
| Chapo, G; Grappiolo, I; Puche, RC; Roveri, EA | 1 |
| Barlow, WE; Ichikawa, LE; LaCroix, AZ; Ott, SM; Scholes, D; Yoshida, CK | 1 |
| Anderson, C; Snow, GR | 2 |
2 review(s) available for medroxyprogesterone acetate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
[Bone loss induced by GnRH agonist treatment].
Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Resorption; Diphosphonates; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Selective Estrogen Receptor Modulators | 2004 |
Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.
Topics: Bone Density; Bone Resorption; Contraceptive Agents, Female; Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Postmenopause; Risk Factors; Time Factors | 2008 |
5 trial(s) available for medroxyprogesterone acetate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
[Effect of vitamin K2 and estrogen administration on bone formation].
Topics: Amino Acids; Biomarkers; Bone Density; Bone Resorption; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Menopause; Osteocalcin; Osteogenesis; Osteoporosis; Treatment Outcome; Vitamin K 2 | 2004 |
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.
Topics: Administration, Oral; Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Resorption; Drug Combinations; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Genotype; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Raloxifene Hydrochloride; Receptors, Calcitriol; Selective Estrogen Receptor Modulators; Treatment Outcome | 2005 |
Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Body Height; Body Weight; Bone Density; Bone Development; Bone Resorption; Calcitriol; Cross-Sectional Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Femur Neck; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus | 1995 |
Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.
Topics: Administration, Cutaneous; Administration, Oral; Amino Acids; Bone Resorption; Creatinine; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Radioimmunoassay | 1993 |
Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate.
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Bone Density; Bone Resorption; Calcium, Dietary; Double-Blind Method; Estrogen Replacement Therapy; Female; Femur; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis; Ovariectomy; Premenopause; Progesterone Congeners; Thoracic Vertebrae; Weight Gain | 1997 |
11 other study(ies) available for medroxyprogesterone acetate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Bone density and contraception in adolescent girls.
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Case-Control Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Osteogenesis; Time Factors | 2004 |
Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive.
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Case-Control Studies; Contraceptives, Oral; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Prospective Studies; Time Factors | 2004 |
Long-acting methods of contraception.
Topics: Adolescent; Adult; Bone Density; Bone Resorption; Contraception; Delayed-Action Preparations; Drug Implants; Female; Humans; Medroxyprogesterone Acetate; Progestins | 2006 |
Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine.
Topics: Adolescent; Adolescent Medicine; Bone Density; Bone Resorption; Calcium, Dietary; Contraceptive Agents, Female; Contraindications; Counseling; Delayed-Action Preparations; Drug Labeling; Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Societies, Medical; United States; United States Food and Drug Administration | 2006 |
Bone status after cessation of use of injectable progestin contraceptives.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Black People; Bone Density; Bone Resorption; Calcaneus; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; South Africa; Ultrasonography | 2007 |
Long-term depot-medroxyprogesterone acetate and bone mineral density.
Topics: Absorptiometry, Photon; Adult; Age Factors; Amenorrhea; Body Mass Index; Bone Density; Bone Resorption; Calcium; Case-Control Studies; China; Contraceptive Agents, Female; Female; Femur; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Middle Aged; Regression Analysis; Surveys and Questionnaires | 1999 |
Association of transforming growth factor beta1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis.
Topics: Aged; Amino Acid Substitution; Bone Density; Bone Resorption; Calcitriol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Exons; Female; Gene Frequency; Genotype; Humans; Hydroxycholecalciferols; Japan; Medroxyprogesterone Acetate; Middle Aged; Osteoblasts; Osteoporosis, Postmenopausal; Ovariectomy; Point Mutation; Protein Sorting Signals; Transforming Growth Factor beta; Treatment Outcome | 2000 |
Effects of depot medroxyprogesterone acetate on the calcium metabolism of adult ovariectomized rats.
Topics: Animals; Bone Resorption; Calcium; Feces; Female; Intestinal Absorption; Medroxyprogesterone Acetate; Ovariectomy; Progesterone Congeners; Rats | 2000 |
Effects of contraceptive use on bone biochemical markers in young women.
Topics: Adult; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Contraceptive Agents, Female; Contraceptives, Oral; Delayed-Action Preparations; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Osteocalcin; Osteogenesis; Premenopause; Progestins | 2001 |
The effects of 17 beta-estradiol and progestagen on trabecular bone remodeling in oophorectomized dogs.
Topics: Animals; Bone and Bones; Bone Resorption; Dogs; Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovariectomy; Progesterone | 1986 |
The effects of continuous progestogen treatment on cortical bone remodeling activity in beagles.
Topics: Animals; Bone and Bones; Bone Development; Bone Resorption; Castration; Dogs; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Progesterone | 1985 |